BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 12969898)

  • 1. What are all the things that aspirin does?
    Flower R
    BMJ; 2003 Sep; 327(7415):572-3. PubMed ID: 12969898
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin and its rivals. As your options increase, your choices get harder.
    Harv Mens Health Watch; 2002 Dec; 7(5):1-5. PubMed ID: 12499131
    [No Abstract]   [Full Text] [Related]  

  • 3. [A 100 years of aspirin: a drug with a future?].
    Sánchez García P
    An R Acad Nac Med (Madr); 1997; 114(1):157-63; discussion 164-7. PubMed ID: 9324911
    [No Abstract]   [Full Text] [Related]  

  • 4. Aspirin resistance: does it exist and is it an important clinical problem?
    Eikelboom J
    Clin Adv Hematol Oncol; 2006 Apr; 4(4):268-70. PubMed ID: 16728937
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardioprotective effects of aspirin compromised by other NSAIDs.
    Gottlieb S
    BMJ; 2003 Sep; 327(7414):520. PubMed ID: 12958094
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aspirin. A wonder drug?].
    Diez-Ewald M
    Invest Clin; 1997 Jun; 38(2):59-61. PubMed ID: 9296640
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclooxygenase inhibition in patients with coronary artery disease.
    Frishman WH
    J Am Coll Cardiol; 2004 Feb; 43(4):532-3. PubMed ID: 14975459
    [No Abstract]   [Full Text] [Related]  

  • 8. The coxibs, selective inhibitors of cyclooxygenase-2.
    Rich SA
    N Engl J Med; 2001 Dec; 345(23):1709. PubMed ID: 11759657
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
    Patrono C
    Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
    [No Abstract]   [Full Text] [Related]  

  • 10. Aspirin antiplatelet therapy and nonsteroidal antiinflammatory drugs: comment on the 2002 update of the American College of Rheumatology Guidelines for the Management of Rheumatoid Arthritis.
    Pablos JL
    Arthritis Rheum; 2002 Nov; 46(11):3102. PubMed ID: 12428257
    [No Abstract]   [Full Text] [Related]  

  • 11. [Prescription, monitoring of antithrombotic treatment: 1--antiplatelet agents].
    Drouet L
    Rev Prat; 2007 Nov; 57(18):2045-50. PubMed ID: 18326440
    [No Abstract]   [Full Text] [Related]  

  • 12. COX-2 selective NSAIDs.
    Ryan NS
    Cleve Clin J Med; 2000 Jan; 67(1):67. PubMed ID: 10645679
    [No Abstract]   [Full Text] [Related]  

  • 13. Aspirin and cyclooxygenase-2 inhibitors.
    Armstrong TA
    Am J Health Syst Pharm; 2003 Jul; 60(14):1481. PubMed ID: 12892035
    [No Abstract]   [Full Text] [Related]  

  • 14. An introduction to aspirin, NSAIDs, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part I.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):294-305. PubMed ID: 11769881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An introduction to aspirin, NSAids, and COX-2 inhibitors for the primary prevention of cardiovascular events and cancer and their potential preventive role in bladder carcinogenesis: part II.
    Moyad MA
    Semin Urol Oncol; 2001 Nov; 19(4):306-16. PubMed ID: 11769882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects.
    Mehta JL
    Clin Cardiol; 1998 Dec; 21(12):879-84. PubMed ID: 9853178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An international scientific meeting on aspirin is needed.
    Morgan G
    J Epidemiol Community Health; 2003 May; 57(5):314. PubMed ID: 12700207
    [No Abstract]   [Full Text] [Related]  

  • 18. Variable platelet response to aspirin and clopidogrel in atherothrombotic disease.
    Maree AO; Fitzgerald DJ
    Circulation; 2007 Apr; 115(16):2196-207. PubMed ID: 17452618
    [No Abstract]   [Full Text] [Related]  

  • 19. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
    Morini S; Zullo A
    G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
    [No Abstract]   [Full Text] [Related]  

  • 20. Uncovering the benefits of aspirin.
    Johns Hopkins Med Lett Health After 50; 2007 Feb; 18(12):3. PubMed ID: 17340747
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.